Direxion Daily SandP Biotech Bear 3X ETF (LABD) |
| 5.98 0.02 (0.34%) 08-27 16:00 |
| Open: | 6.01 |
| High: | 6.13 |
| Low: | 5.88 |
| Volume: | 19,849,831 |
| Market Cap: | 14(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management - Leveraged |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 9.98 |
| Resistance 1: | 8.39 |
| Pivot price: | 6.84 |
| Support 1: | 5.81 |
| Support 2: | 4.83 |
| 52w High: | 58.6 |
| 52w Low: | 5.81 |
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 25 Aug 2026
Technical Analysis: Direxion Daily S&P Biotech Bull, Bear 3X ETF (LABU, LABD) Prices Are Trending - Benzinga
Wed, 27 May 2026
5 Small-cap Biotech ETFs to Watch in 2026 - Investing News Network
Tue, 28 Apr 2026
Biotech, Banks, and Bonds: Trading the Fed’s April Meeting - Direxion
Fri, 27 Mar 2026
U.S. ETF Express | 2x Long VIX Futures ETF Was the Top Gainer, Rising 15.16% - Moomoo
Mon, 02 Feb 2026
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
Fri, 19 Dec 2025
Leveraged ETFs - Intellectia AI
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
